OBGYN.net Conference CoverageFrom 3rd Regional Meeting of the International Society for Gynecologic Endoscopy - Cairo, Egypt - 1999
Audio/Video Link *requires RealPlayer - free download
Dr. James Carter: “We’re in Cairo at the ISGE meeting - welcome.”
Professor Ayman Assaf: “My name is Ayman Assaf, I am the Chairman of the Organizing Committee for the 3rd Regional Meeting of the International Society for Gynecologic Endoscopy. Actually, the Society decided to make the Regional meeting a topical meeting, and the topic for this Congress is "Controversies in Gynecological Endoscopy". As you all know, this field is full of controversies and for that reason we chose this topic. The scientific program consists of presentation from high caliber national and international speakers covering most of the controversial points. I hope that we’ll be able to reach a consensus in some of them. However, I feel it is a must that we cool down the hot discussion, at least to keep away from the so-called clear course of failures. Also, the social program has been planned for you to enjoy your stay here from meeting old friends and making new ones. I would like to welcome all our guests, and I wish a pleasant stay for our colleagues. Thank you very much.”
Dr. James Carter: “Thank you.”
Disparities in kidney care access for pregnant patients
December 11th 2023A recent study highlights significant disparities in kidney transplant and nephrology care access for pregnant patients with end-stage kidney disease, revealing reduced survival rates and limited access to crucial care compared to non-pregnancy-related causes.
Read More
Mediterranean diet linked to improved pregnancy outcomes
December 8th 2023A comprehensive meta-analysis scrutinizes the Mediterranean diet's impact on female reproductive health, uncovering compelling evidence that links this nutritional approach to a significant reduction in adverse pregnancy outcomes.
Read More
FDA grants IND clearance to DARE-VVA1 for dyspareunia
December 7th 2023Daré Bioscience's tamoxifen-based therapy, DARE-VVA1, secures FDA clearance for an investigational new drug application, offering hope for women with contraindications to estrogen therapies suffering from the underdiagnosed condition of vulvar and vaginal atrophy.
Read More